United Therapeutics
Price & Volume
Stats
See more52W Range | $452.44-$614.23 |
Market Cap | $24.8B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $3.1B |
Revenue Growth (YoY) | 4.1% |
Gross Profit (12 Mos) | $2.7B |
Diluted EPS | $26.49 |
News
See moreYahoo Finance • 4 days ago
SPDR S&P MidCap 400 ETF (MDY) Adds Glaukos and United Therapeutics on Wednesday
Yahoo Finance • 5 days ago
iShares Core S&P Mid-Cap (IJH) Adds Glaukos and TechnipFMC on Nov. 3
Yahoo Finance • 7 days ago
United Therapeutics Q3 2026 Earnings Preview
Yahoo Finance • 8 days ago
iShares Core S&P Mid-Cap (IJH) Adds Okta and TechnipFMC on Oct. 29
About
CEO | Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. |
CFO | Mr. James C. Edgemond |
Address | 1000 Spring Street, Silver Spring, MD, United States, 20910 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,400 |